{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:54Z","timestamp":1794047454045,"version":"4.8.0"},"reference-count":56,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"5","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Mutations in the ELANE gene, encoding the neutrophil elastase (NE) protein, are responsible for most cyclic neutropenia (CyN) cases and approximately 25% of congenital neutropenia (CN) cases. In CN and in CyN, a median of 2.8% of CD34+ cells were early CD49f+ hematopoietic stem cells (eHSC) that did not express ELANE and thus escape from the unfolded protein response (UPR) caused by mutated NE. In CyN, the CD49f+ cells respond to granulocyte colony-stimulating factor (G-CSF) with a significant upregulation of the hematopoietic stem cell-specific transcription factors, C\/EBP\u03b1, MLL1, HOXA9, MEIS1, and HLF during the ascending arm of the cycle, resulting in the differentiation of myeloid cells to mature neutrophils at the cycle peak. However, NE protein released by neutrophils at the cycle\u2019s peak caused a negative feedback loop on granulopoiesis through the proteolytic digestion of G-CSF. In contrast, in CN patients, CD49f+ cells failed to express mRNA levels of HSC-specific transcription factors mentioned above. Rescue of C\/EBP\u03b1 expression in CN restored granulopoiesis.<\/jats:p>","DOI":"10.3324\/haematol.2023.284033","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T03:36:53Z","timestamp":1697686613000},"page":"1393-1402","source":"Crossref","is-referenced-by-count":0,"title":["Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring &lt;i&gt;ELANE&lt;\/i&gt; mutations"],"prefix":"10.3324","volume":"109","author":[{"given":"Alexander","family":"Zeidler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Borbaran-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dannenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Nasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim","family":"Klimiankou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Kandabarau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Zahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Zeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Skokowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"60374","doi-asserted-by":"crossref","unstructured":"Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017; 3:17032.","DOI":"10.1038\/nrdp.2017.32"},{"key":"60375","doi-asserted-by":"crossref","unstructured":"Makaryan V, Zeidler C, Bolyard AA. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol. 2015; 22(1):3-11.","DOI":"10.1097\/MOH.0000000000000105"},{"key":"60376","doi-asserted-by":"crossref","unstructured":"Dale DC, Welte K. Cyclic and chronic neutropenia. Cancer Treat Res. 2011; 157:97-108.","DOI":"10.1007\/978-1-4419-7073-2_6"},{"key":"60377","doi-asserted-by":"crossref","unstructured":"Bonilla MA, Dale D, Zeidler C. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol. 1994; 88(4):723-730.","DOI":"10.1111\/j.1365-2141.1994.tb05110.x"},{"key":"60378","doi-asserted-by":"crossref","unstructured":"Hammond WP, Price TH, Souza LM, Dale DC. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med. 1989; 320(20):1306-1311.","DOI":"10.1056\/NEJM198905183202003"},{"key":"60379","doi-asserted-by":"crossref","unstructured":"Bonilla MA, Gillio AP, Ruggeiro M. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989; 320(24):1574-1580.","DOI":"10.1056\/NEJM198906153202402"},{"key":"60380","doi-asserted-by":"crossref","unstructured":"Dale DC, Bolyard A, Marrero T. Long-term effects of G-CSF therapy in cyclic neutropenia. N Engl J Med. 2017; 377(23):2290-2292.","DOI":"10.1056\/NEJMc1709258"},{"key":"60381","doi-asserted-by":"crossref","unstructured":"Klimiankou M, Uenalan M, Kandabarau S. Ultra-sensitive CSF3R deep sequencing in patients with severe congenital neutropenia. Front Immunol. 2019; 10:116.","DOI":"10.3389\/fimmu.2019.00116"},{"key":"60382","doi-asserted-by":"crossref","unstructured":"Skokowa J, Steinemann D, Katsman-Kuipers JE. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. 2014; 123(14):2229-2237.","DOI":"10.1182\/blood-2013-11-538025"},{"key":"60383","doi-asserted-by":"crossref","unstructured":"Rosenberg PS, Zeidler C, Bolyard AA. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol. 2010; 150(2):196-199.","DOI":"10.1111\/j.1365-2141.2010.08216.x"},{"key":"60384","doi-asserted-by":"crossref","unstructured":"Klimiankou M, Mellor-Heineke S, Klimenkova O. Two cases of cyclic neutropenia with acquired CSF3R mutations, with 1 developing AML. Blood. 2016; 127(21):2638-2641.","DOI":"10.1182\/blood-2015-12-685784"},{"key":"60385","doi-asserted-by":"crossref","unstructured":"Nustede R, Klimiankou M, Klimenkova O. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia. Br J Haematol. 2016; 172(2):219-227.","DOI":"10.1111\/bjh.13823"},{"key":"60386","doi-asserted-by":"crossref","unstructured":"Nayak RC, Trump LR, Aronow BJ. Pathogenesis of ELANEmutant severe neutropenia revealed by induced pluripotent stem cells. J Clin Invest. 2015; 125(8):3103-3116.","DOI":"10.1172\/JCI80924"},{"key":"60387","doi-asserted-by":"crossref","unstructured":"Dannenmann B, Zahabi A, Mir P. Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation. Exp Hematol. 2019; 71:51-60.","DOI":"10.1016\/j.exphem.2018.12.006"},{"key":"60388","doi-asserted-by":"crossref","unstructured":"Velten L, Haas SF, Raffel S. Human haematopoietic stem cell lineage commitment is a continuous process. Nat Cell Biol. 2017; 19(4):271-281.","DOI":"10.1038\/ncb3493"},{"key":"60389","doi-asserted-by":"crossref","unstructured":"Mir P, Klimiankou M, Findik B. New insights into the pathomechanism of cyclic neutropenia. Ann N Y Acad Sci. 2020; 1466(1):83-92.","DOI":"10.1111\/nyas.14309"},{"key":"60390","doi-asserted-by":"crossref","unstructured":"Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JE. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science. 2011; 333(6039):218-221.","DOI":"10.1126\/science.1201219"},{"key":"60391","doi-asserted-by":"crossref","unstructured":"Belluschi S, Calderbank EF, Ciaurro V. Myelo-lymphoid lineage restriction occurs in the human haematopoietic stem cell compartment before lymphoid-primed multipotent progenitors. Nat Commun. 2018; 9(1):4100.","DOI":"10.1038\/s41467-018-06442-4"},{"key":"60392","doi-asserted-by":"crossref","unstructured":"Krebsbach PH, Villa-Diaz LG. The role of integrin \u03b16 (CD49f) in stem cells: more than a conserved biomarker. Stem Cell Dev. 2017; 26(15):1090-1099.","DOI":"10.1089\/scd.2016.0319"},{"key":"60393","doi-asserted-by":"crossref","unstructured":"Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG. CCAAT\/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol. 1998; 18(7):4301-4314.","DOI":"10.1128\/MCB.18.7.4301"},{"key":"60394","doi-asserted-by":"crossref","unstructured":"Iida S, Watanabe-Fukunaga R, Nagata S, Fukunaga R. Essential role of C\/EBPalpha in G-CSF-induced transcriptional activation and chromatin modification of myeloid-specific genes. Genes Cells. 2008; 13(4):313-327.","DOI":"10.1111\/j.1365-2443.2008.01173.x"},{"key":"60395","doi-asserted-by":"crossref","unstructured":"Avellino R, Mulet-Lazaro R, Havermans M. Induced cell-autonomous neutropenia systemically perturbs hematopoiesis in Cebpa enhancer-null mice. Blood Adv. 2022; 6(5):1406-1419.","DOI":"10.1182\/bloodadvances.2021005851"},{"key":"60396","doi-asserted-by":"crossref","unstructured":"Collins C, Wang J, Miao H. C\/EBPalpha is an essential collaborator in Hoxa9\/Meis1-mediated leukemogenesis. Proc Natl Acad Sci U S A. 2014; 111(27):9899-9904.","DOI":"10.1073\/pnas.1402238111"},{"key":"60397","doi-asserted-by":"crossref","unstructured":"Artinger EL, Mishra BP, Zaffuto KM. An MLL-dependent network sustains hematopoiesis. Proc Natl Acad Sci U S A. 2013; 110(29):12000-12005.","DOI":"10.1073\/pnas.1301278110"},{"key":"60398","doi-asserted-by":"crossref","unstructured":"Milne TA, Briggs SD, Brock HW. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell. 2002; 10(5):1107-117.","DOI":"10.1016\/S1097-2765(02)00741-4"},{"key":"60399","doi-asserted-by":"crossref","unstructured":"Hasemann MS, Lauridsen FK, Waage J. C\/EBPalpha is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors. PLoS Genet. 2014; 10(1):e1004079.","DOI":"10.1371\/journal.pgen.1004079"},{"key":"60400","doi-asserted-by":"crossref","unstructured":"Ye M, Zhang H, Amabile G. C\/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol. 2013; 15(4):385-394.","DOI":"10.1038\/ncb2698"},{"key":"60401","doi-asserted-by":"crossref","unstructured":"Skokowa J, Cario G, Uenalan M. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med. 2006; 12(10):1191-1197.","DOI":"10.1038\/nm1474"},{"key":"60402","doi-asserted-by":"crossref","unstructured":"Dannenmann B, Klimiankou M, Oswald B. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia. Cell Stem Cell. 2021; 28(5):906-922.","DOI":"10.1016\/j.stem.2021.03.023"},{"key":"60403","doi-asserted-by":"crossref","unstructured":"Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc Natl Acad Sci U S A. 2001; 98(23):13120-13125.","DOI":"10.1073\/pnas.231115398"},{"key":"60404","doi-asserted-by":"crossref","unstructured":"Pineault N, Helgason CD, Lawrence HJ, Humphries RK. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol. 2002; 30(1):49-57.","DOI":"10.1016\/S0301-472X(01)00757-3"},{"key":"60405","doi-asserted-by":"crossref","unstructured":"Argiropoulos B, Yung E, Humphries RK. Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis. Genes Dev. 2007; 21(22):2845-2849.","DOI":"10.1101\/gad.1619407"},{"key":"60406","doi-asserted-by":"crossref","unstructured":"Lawrence HJ, Christensen J, Fong S. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood. 2005; 106(12):3988-3994.","DOI":"10.1182\/blood-2005-05-2003"},{"key":"60407","doi-asserted-by":"crossref","unstructured":"Thorsteinsdottir U, Mamo A, Kroon E. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood. 2002; 99(1):121-129.","DOI":"10.1182\/blood.V99.1.121"},{"key":"60408","doi-asserted-by":"crossref","unstructured":"Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene. 2007; 26(47):6766-6776.","DOI":"10.1038\/sj.onc.1210760"},{"key":"60409","doi-asserted-by":"crossref","unstructured":"Lehnertz B, Chagraoui J, MacRae T. HLF expression defines the human hematopoietic stem cell state. Blood. 2021; 138(25):2642-2654.","DOI":"10.1182\/blood.2021010745"},{"key":"60410","doi-asserted-by":"crossref","unstructured":"Giladi A, Paul F, Herzog Y. Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis. Nat Cell Biol. 2018; 20(7):836-846.","DOI":"10.1038\/s41556-018-0121-4"},{"key":"60411","doi-asserted-by":"crossref","unstructured":"Fioredda F, Skokowa J, Tamary H. The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: a consensus between the European Hematology Association and the EuNet-INNOCHRON COST action. Hemasphere. 2023; 7(4):e872.","DOI":"10.1097\/HS9.0000000000000872"},{"key":"60412","doi-asserted-by":"crossref","unstructured":"Hammond CA, Eaves C. Postnatal conservation of human blood- and marrow-specific CD34+ hematopoietic phenotypes. Exp Hematol. 2022; 109:18-26.","DOI":"10.1016\/j.exphem.2022.03.004"},{"key":"60413","doi-asserted-by":"crossref","unstructured":"Cheneby J, Menetrier Z, Mestdagh M. ReMap 2020: a database of regulatory regions from an integrative analysis of human and arabidopsis DNA-binding sequencing experiments. Nucleic Acids Res. 2020; 48(D1):D180-D188.","DOI":"10.1093\/nar\/gkz945"},{"key":"60414","doi-asserted-by":"crossref","unstructured":"Huang Y, Sitwala K, Bronstein J. Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood. 2012; 119(2):388-398.","DOI":"10.1182\/blood-2011-03-341081"},{"key":"60415","doi-asserted-by":"crossref","unstructured":"Dannenmann B, Nasri M, Welte K, Skokowa J. CRISPR\/Cas9 genome editing of human-induced pluripotent stem cells followed by granulocytic differentiation. Methods Mol Biol. 2020; 2115:471-483.","DOI":"10.1007\/978-1-0716-0290-4_27"},{"key":"60416","doi-asserted-by":"crossref","unstructured":"Ramos-Mej\u00eda V, Navarro-Montero O, Ayllon V. HOXA9 promotes hematopoietic commitment of human embryonic stem cells. Blood. 2014; 124(20):3065-3075.","DOI":"10.1182\/blood-2014-03-558825"},{"key":"60417","doi-asserted-by":"crossref","unstructured":"Knapp DJ, Hammond CA, Aghaeepour N. Distinct signaling programs control human hematopoietic stem cell survival and proliferation. Blood. 2017; 129(3):307-318.","DOI":"10.1182\/blood-2016-09-740654"},{"key":"60418","unstructured":"Morley A. Cyclic hemopoiesis and feedback control. Blood Cells. 1979; 5(2):283-296."},{"key":"60419","doi-asserted-by":"crossref","unstructured":"von Schulthess GK, Mazer NA. Cyclic neutropenia (CN): a clue to the control of granulopoiesis. Blood. 1982; 59(1):27-37.","DOI":"10.1182\/blood.V59.1.27.27"},{"key":"60420","doi-asserted-by":"crossref","unstructured":"Horwitz MS, Duan Z, Korkmaz B, Lee HH, Mealiffe ME, Salipante SJ. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood. 2007; 109(5):1817-1824.","DOI":"10.1182\/blood-2006-08-019166"},{"key":"60421","doi-asserted-by":"crossref","unstructured":"Hunter MG, Druhan LJ, Massullo PR, Avalos BR. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor. Am J Hematol. 2003; 74(3):149-155.","DOI":"10.1002\/ajh.10434"},{"key":"60422","doi-asserted-by":"crossref","unstructured":"El Ouriaghli F, Fujiwara H, Melenhorst JJ, Sconocchia G, Hensel N, Barrett AJ. Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis. Blood. 2003; 101(5):1752-1758.","DOI":"10.1182\/blood-2002-06-1734"},{"key":"60423","doi-asserted-by":"crossref","unstructured":"Skokowa J, Hernandez Alvarez B, Coles M. A topological refactoring design strategy yields highly stable granulopoietic proteins. Nat Commun. 2022; 13(1):2948.","DOI":"10.1038\/s41467-022-30157-2"},{"key":"60424","doi-asserted-by":"crossref","unstructured":"Li FQ, Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem. 2001; 276(17):14230-14241.","DOI":"10.1074\/jbc.M010279200"},{"key":"60425","doi-asserted-by":"crossref","unstructured":"Horwitz M, Benson KF, Duan Z. Role of neutrophil elastase in bone marrow failure syndromes: molecular genetic revival of the chalone hypothesis. Curr Opin Hematol. 2003; 10(1):49-54.","DOI":"10.1097\/00062752-200301000-00008"},{"key":"60426","doi-asserted-by":"crossref","unstructured":"Skokowa J, Fobiwe JP, Dan L, Thakur BK, Welte K. Neutrophil elastase is severely down-regulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF-1. Blood. 2009; 114(14):3044-3051.","DOI":"10.1182\/blood-2008-11-188755"},{"key":"60427","doi-asserted-by":"crossref","unstructured":"Watari K, Asano S, Shirafuji N. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood. 1989; 73(1):117-122.","DOI":"10.1182\/blood.V73.1.117.117"},{"key":"60428","doi-asserted-by":"crossref","unstructured":"Makaryan V, Kelley ML, Fletcher B, Bolyard AA, Aprikyan AA, Dale DC. Elastase inhibitors as potential therapies for ELANE-associated neutropenia. J Leukoc Biol. 2017; 102(4):1143-1151.","DOI":"10.1189\/jlb.5A1016-445R"},{"key":"60429","doi-asserted-by":"crossref","unstructured":"Skokowa J. Circumventing mutation to nix neutropenia. N Engl J Med. 2021; 384(20):1956-1958.","DOI":"10.1056\/NEJMcibr2102952"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284033\/76178","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284033\/76933","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11314\/76178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:04Z","timestamp":1794045904000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284033","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,19]]}}}